JP2024112834A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024112834A5 JP2024112834A5 JP2024075968A JP2024075968A JP2024112834A5 JP 2024112834 A5 JP2024112834 A5 JP 2024112834A5 JP 2024075968 A JP2024075968 A JP 2024075968A JP 2024075968 A JP2024075968 A JP 2024075968A JP 2024112834 A5 JP2024112834 A5 JP 2024112834A5
- Authority
- JP
- Japan
- Prior art keywords
- antisense oligonucleotide
- linkage
- sarm1
- seq
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962940437P | 2019-11-26 | 2019-11-26 | |
| US62/940,437 | 2019-11-26 | ||
| JP2022530807A JP7528212B2 (ja) | 2019-11-26 | 2020-11-25 | 神経保護のための方法および組成物 |
| PCT/US2020/062289 WO2021108602A1 (en) | 2019-11-26 | 2020-11-25 | Methods and compositions for neuroprotection |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530807A Division JP7528212B2 (ja) | 2019-11-26 | 2020-11-25 | 神経保護のための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024112834A JP2024112834A (ja) | 2024-08-21 |
| JP2024112834A5 true JP2024112834A5 (enExample) | 2024-11-11 |
| JP7796797B2 JP7796797B2 (ja) | 2026-01-09 |
Family
ID=74046136
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530807A Active JP7528212B2 (ja) | 2019-11-26 | 2020-11-25 | 神経保護のための方法および組成物 |
| JP2024075968A Active JP7796797B2 (ja) | 2019-11-26 | 2024-05-08 | 神経保護のための方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022530807A Active JP7528212B2 (ja) | 2019-11-26 | 2020-11-25 | 神経保護のための方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12595481B2 (enExample) |
| EP (1) | EP4065714A1 (enExample) |
| JP (2) | JP7528212B2 (enExample) |
| KR (1) | KR20220119366A (enExample) |
| CN (1) | CN115176002A (enExample) |
| AU (1) | AU2020391206A1 (enExample) |
| BR (1) | BR112022009772A2 (enExample) |
| IL (1) | IL293123A (enExample) |
| MX (1) | MX2022006146A (enExample) |
| TW (1) | TW202134436A (enExample) |
| WO (1) | WO2021108602A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7528212B2 (ja) * | 2019-11-26 | 2024-08-05 | ディスアーム セラピューティクス， インコーポレイテッド | 神経保護のための方法および組成物 |
| PE20242222A1 (es) * | 2022-03-14 | 2024-11-19 | Lilly Co Eli | Agentes de interferencia de arn de sarm1 |
| CN116059367B (zh) * | 2022-07-15 | 2025-02-18 | 浙江乘时佳生物科技有限公司 | 一种治疗阿尔茨海默症的sarm1抑制剂 |
| US20240102018A1 (en) * | 2022-07-21 | 2024-03-28 | Amylyx Pharmaceuticals, Inc. | Oligonucleotide compositions and methods thereof |
| TW202547525A (zh) | 2024-02-02 | 2025-12-16 | 美商美國禮來大藥廠 | SARM1 RNAi藥劑 |
| GB202408068D0 (en) | 2024-06-06 | 2024-07-24 | Univ London | Treatment of cancer of the central nervous system |
| WO2025261431A1 (zh) * | 2024-06-19 | 2025-12-26 | 上海拓界生物医药科技有限公司 | 靶向SARM1的RNAi剂及其医药用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040096830A1 (en) | 2002-11-16 | 2004-05-20 | Isis Pharmaceuticals Inc. | Modulation of protein kinase D2 expression |
| US7250496B2 (en) * | 2002-11-14 | 2007-07-31 | Rosetta Genomics Ltd. | Bioinformatically detectable group of novel regulatory genes and uses thereof |
| US20050244851A1 (en) * | 2004-01-13 | 2005-11-03 | Affymetrix, Inc. | Methods of analysis of alternative splicing in human |
| JP5697297B2 (ja) * | 2004-05-14 | 2015-04-08 | ロゼッタ ジノミクス リミテッド | マイクロｎａｓおよびその使用 |
| US7901882B2 (en) * | 2006-03-31 | 2011-03-08 | Affymetrix, Inc. | Analysis of methylation using nucleic acid arrays |
| JP2013003911A (ja) * | 2011-06-17 | 2013-01-07 | Sony Corp | 電子機器、電子機器の制御方法およびプログラム |
| WO2012178022A2 (en) * | 2011-06-24 | 2012-12-27 | University Of Massachusetts | Therapeutic applications targeting sarm1 |
| CN107921148A (zh) | 2015-05-08 | 2018-04-17 | 哈佛学院校长同事会 | 通用供体干细胞和相关方法 |
| JP7198489B2 (ja) | 2016-03-23 | 2023-01-04 | 国立大学法人 岡山大学 | リン酸化ｓａｒｍ１、抗体、ｓａｒｍ１リン酸化阻害剤、神経変性疾患の予防又は治療薬、スクリーニング方法、ｓａｒｍ１改変体及び使用 |
| CN109843914B (zh) | 2016-07-06 | 2024-03-15 | 沃泰克斯药物股份有限公司 | 用于治疗疼痛相关病症的材料和方法 |
| JP7044789B2 (ja) | 2016-09-24 | 2022-03-30 | ワシントン・ユニバーシティ | Ｓａｒｍ１ ｎａｄアーゼ活性の阻害剤およびその使用 |
| WO2018154413A1 (en) * | 2017-02-22 | 2018-08-30 | Crispr Therapeutics Ag | Materials and methods for treatment of dystrophic epidermolysis bullosa (deb) and other collagen type vii alpha 1 chain (col7a1) gene related conditions or disorders |
| EP3697401B1 (en) | 2017-10-18 | 2025-12-03 | Washington University | Dominant negative sarm1 molecules as a therapeutic strategy for neurodegenerative diseases or disorders |
| CN112839648B (zh) | 2018-06-07 | 2025-04-04 | 达萨玛治疗公司 | Sarm1抑制剂 |
| CN112839647B (zh) | 2018-06-07 | 2025-09-23 | 达萨玛治疗公司 | Sarm1抑制剂 |
| CA3108669A1 (en) | 2018-06-07 | 2019-12-12 | Disarm Therapeutics, Inc. | Inhibitors of sarm1 |
| JP7528212B2 (ja) | 2019-11-26 | 2024-08-05 | ディスアーム セラピューティクス， インコーポレイテッド | 神経保護のための方法および組成物 |
-
2020
- 2020-11-25 JP JP2022530807A patent/JP7528212B2/ja active Active
- 2020-11-25 IL IL293123A patent/IL293123A/en unknown
- 2020-11-25 KR KR1020227017020A patent/KR20220119366A/ko not_active Withdrawn
- 2020-11-25 TW TW109141403A patent/TW202134436A/zh unknown
- 2020-11-25 MX MX2022006146A patent/MX2022006146A/es unknown
- 2020-11-25 US US17/778,567 patent/US12595481B2/en active Active
- 2020-11-25 AU AU2020391206A patent/AU2020391206A1/en not_active Abandoned
- 2020-11-25 CN CN202080082124.2A patent/CN115176002A/zh active Pending
- 2020-11-25 BR BR112022009772A patent/BR112022009772A2/pt not_active IP Right Cessation
- 2020-11-25 EP EP20829411.6A patent/EP4065714A1/en active Pending
- 2020-11-25 WO PCT/US2020/062289 patent/WO2021108602A1/en not_active Ceased
-
2024
- 2024-05-08 JP JP2024075968A patent/JP7796797B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024112834A5 (enExample) | ||
| US11920132B2 (en) | Oligonucleotide therapy for Leber congenital amaurosis | |
| US5194428A (en) | Inhibition of influenza virus replication by oligonucleotide phosphorothioates | |
| US6372427B1 (en) | Cooperative oligonucleotides | |
| CN115697420A (zh) | 一种治疗赫勒氏综合征的方法和药物 | |
| CN115516092A (zh) | 血管生成素样3(ANGPTL3)的siRNA及其用途 | |
| CA2457528A1 (en) | Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) | |
| KR20080031164A (ko) | ＳＲ 단백질의 결합의 방해에 의해 그리고 이차 ＲＮＡ구조의 방해에 의한 ｐｒｅ－ｍＲＮＡ에서 엑손 인식의조절 | |
| JPH08510900A (ja) | 改良された抗インフルエンザ活性を有する修飾オリゴヌクレオチド | |
| JP2022520986A5 (enExample) | ||
| US5637573A (en) | Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions | |
| JP2022536945A5 (enExample) | ||
| JP2023542889A5 (enExample) | ||
| JP2024073525A5 (enExample) | ||
| JP2024506709A5 (enExample) | ||
| US5650502A (en) | Ribozyme analogs having rigid non-nucleotidic linkers | |
| CN115702006A (zh) | 缀合基团及其缀合物 | |
| JP2024536132A5 (enExample) | ||
| JP2024524974A5 (enExample) | ||
| WO2017186815A1 (en) | Antisense oligonucleotides for enhanced expression of frataxin | |
| JP2021513851A5 (enExample) | ||
| WO1997038097A1 (en) | Cooperative oligonucleotides | |
| RU2024106447A (ru) | Антисмысловые олигонуклеотиды, нацеленные на ген cav3.1, и их применения | |
| AU2003236659B2 (en) | Cooperative oligonucleotides | |
| JP2024518788A5 (enExample) |